ARCHIVES

NCI’s Professional Judgment Budget Outlines Spending of $7.2 Billion

This article is from The Cancer Letter archive.

Vol. 35 No. 06 | February 13, 2009

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Groups Recognized By ASCO For 50+ Years Of Clinical Trials.

June 1, 2007

Clolar Approved for Pediatric Refractory/Relapsed ALL

January 28, 2005

DCT Advisors Reject MRS Concept, Approve RDOG Expansion

November 30, 1990

DCBD Board Approves Concept for Astrocytoma Molecular Probes

July 22, 1988

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

December 28, 2012

In Brief: Lasker Awards; Blobel, Metcalf, Wexler, Rogers; Borch Named Center Director

October 1, 1993